Private Healthcare Ecosystem Manager at Eli Lilly and Company

Warsaw, Woj. Mazowieckie, Poland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Bachelor's degree; Post-graduate degree or MBA preferred
5+ years of work experience in private ecosystem related space
Fluent in English (mandatory)
Previous B2B experience with the private ecosystem environment (private healthcare/pharmacy chains) is preferred
Strong analytical, planning, and organizational skills
Proven track record of achieving business results
Innovative and entrepreneurial mindset
Excellent communication & presentation skills
Strong strategic thinking and business acumen
Ability to handle multiple projects simultaneously, with time management skills
A strong professional work ethic
A positive, energetic attitude
Ability to work under pressure
Strong interpersonal and collaborative skills

Responsibilities

Identify, initiate and manage strategic partnerships with private healthcare providers and ecosystem players that are aligned with the overall business goals for the Lilly Poland portfolio in the private health space
Co-create value-driven offerings with partners that may include patient support programs, digital health integration and outcomes-based initiatives
Lead commercial decisions, build and manage long-term relationships with B2B partners and work closely with legal, finance, compliance & PRA (Pricing, Reimbursement, Access)
Support marketing teams with insights and training on private healthcare dynamics to enable development and delivery of effective tactics and integrated solutions
Analyze private sector healthcare trends, competitor activities, and unmet needs to identify growth opportunities in the private ecosystem space
Work closely with sales, marketing and medical
Serve as the primary point of contact for all internal stakeholders regarding private health strategy for the BUs
Establish KPIs to measure the effectiveness of private health initiatives
Drive continuous improvement based on feedback, data, and market trends

Skills

Key Account Management

Strategic Partnerships

Business Development

Negotiation

Project Management

Value Proposition Design

B2B Relationship Management

Patient Support Programs

Digital Health Integration

Outcomes-Based Initiatives

Commercial Decision-Making

Cross-Functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free